These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 25993548)

  • 21. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.
    Jimenez-Andrade JM; Ghilardi JR; Castañeda-Corral G; Kuskowski MA; Mantyh PW
    Pain; 2011 Nov; 152(11):2564-2574. PubMed ID: 21907491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
    Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
    Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minocycline-induced reduction of brain-derived neurotrophic factor expression in relation to cancer-induced bone pain in rats.
    Wang LN; Yang JP; Zhan Y; Ji FH; Wang XY; Zuo JL; Xu QN
    J Neurosci Res; 2012 Mar; 90(3):672-81. PubMed ID: 22057846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trabectedin Reduces Skeletal Prostate Cancer Tumor Size in Association with Effects on M2 Macrophages and Efferocytosis.
    Jones JD; Sinder BP; Paige D; Soki FN; Koh AJ; Thiele S; Shiozawa Y; Hofbauer LC; Daignault S; Roca H; McCauley LK
    Neoplasia; 2019 Feb; 21(2):172-184. PubMed ID: 30591422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.
    Wang XF; Wang YJ; Li TY; Guo JX; Lv F; Li CL; Ge XT
    Biomed Pharmacother; 2019 Jul; 115():108916. PubMed ID: 31054506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines.
    Hu S; Mao-Ying QL; Wang J; Wang ZF; Mi WL; Wang XW; Jiang JW; Huang YL; Wu GC; Wang YQ
    J Neuroinflammation; 2012 Dec; 9():278. PubMed ID: 23268791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. JNK in spinal cord facilitates bone cancer pain in rats through modulation of CXCL1.
    Wang ZL; Du TT; Zhang RG
    J Huazhong Univ Sci Technolog Med Sci; 2016 Feb; 36(1):88-94. PubMed ID: 26838746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
    Arnold RS; Sun CQ; Richards JC; Grigoriev G; Coleman IM; Nelson PS; Hsieh CL; Lee JK; Xu Z; Rogatko A; Osunkoya AO; Zayzafoon M; Chung L; Petros JA
    Prostate; 2009 Jan; 69(1):1-11. PubMed ID: 18850577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sulforaphane alleviates hyperalgesia and enhances analgesic potency of morphine in rats with cancer-induced bone pain.
    Fu J; Xu M; Xu L; Ni H; Zhao B; Ni C; Huang M; Zhu J; Luo G; Yao M
    Eur J Pharmacol; 2021 Oct; 909():174412. PubMed ID: 34375671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain.
    Zhang H; Lund DM; Ciccone HA; Staatz WD; Ibrahim MM; Largent-Milnes TM; Seltzman HH; Spigelman I; Vanderah TW
    Pain; 2018 Sep; 159(9):1814-1823. PubMed ID: 29781960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain.
    Saito O; Aoe T; Yamamoto T
    J Anesth; 2005; 19(3):218-24. PubMed ID: 16032450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tanshinone IIA Exerts an Antinociceptive Effect in Rats with Cancer-induced Bone Pain.
    Hao W; Chen L; Wu LF; Yang F; Niu JX; Kaye AD; Xu SY
    Pain Physician; 2016; 19(7):465-76. PubMed ID: 27676663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of Spinal GABAB Receptors in Cancer-Induced Bone Pain in Rats.
    Zhou YQ; Chen SP; Liu DQ; Manyande A; Zhang W; Yang SB; Xiong BR; Fu QC; Song ZP; Rittner H; Ye DW; Tian YK
    J Pain; 2017 Aug; 18(8):933-946. PubMed ID: 28323246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord.
    Wang LN; Yao M; Yang JP; Peng J; Peng Y; Li CF; Zhang YB; Ji FH; Cheng H; Xu QN; Wang XY; Zuo JL
    Mol Pain; 2011 Jul; 7():48. PubMed ID: 21722369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model.
    Ohno H; Kubo K; Murooka H; Kobayashi Y; Nishitoba T; Shibuya M; Yoneda T; Isoe T
    Mol Cancer Ther; 2006 Nov; 5(11):2634-43. PubMed ID: 17121910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study.
    Butowski N; Colman H; De Groot JF; Omuro AM; Nayak L; Wen PY; Cloughesy TF; Marimuthu A; Haidar S; Perry A; Huse J; Phillips J; West BL; Nolop KB; Hsu HH; Ligon KL; Molinaro AM; Prados M
    Neuro Oncol; 2016 Apr; 18(4):557-64. PubMed ID: 26449250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modulation of bone microenvironment with zoledronate enhances the therapeutic effects of STI571 and paclitaxel against experimental bone metastasis of human prostate cancer.
    Kim SJ; Uehara H; Yazici S; He J; Langley RR; Mathew P; Fan D; Fidler IJ
    Cancer Res; 2005 May; 65(9):3707-15. PubMed ID: 15867366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The PI3K inhibitor buparlisib suppresses osteoclast formation and tumour cell growth in bone metastasis of lung cancer, as evidenced by multimodality molecular imaging.
    Wang S; Niu X; Bao X; Wang Q; Zhang J; Lu S; Wang Y; Xu L; Wang M; Zhang J
    Oncol Rep; 2019 May; 41(5):2636-2646. PubMed ID: 30896825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Astrocyte activation in the periaqueductal gray promotes descending facilitation to cancer-induced bone pain through the JNK MAPK signaling pathway.
    Ni HD; Xu LS; Wang Y; Li H; An K; Liu M; Liu Q; Deng H; He Q; Huang B; Fang J; Yao M
    Mol Pain; 2019; 15():1744806919831909. PubMed ID: 30700204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.
    Sabino MA; Ghilardi JR; Jongen JL; Keyser CP; Luger NM; Mach DB; Peters CM; Rogers SD; Schwei MJ; de Felipe C; Mantyh PW
    Cancer Res; 2002 Dec; 62(24):7343-9. PubMed ID: 12499278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.